The global medical affairs outsourcing market, valued at $1.85b in 2024, is projected to reach $2.83b by 2028 at a compound annual growth rate of 11.2%, according to Research and Markets.
The sector’s expansion is attributed to the rising number of patent expirations, advancements in communication technologies, and the rapid development of the life sciences sector.
Moreover, the growing prevalence of infectious diseases has further driven the demand for medical affairs outsourcing to support enhanced interventions and disease management.
AI-driven platforms are being adopted to enable more efficient data management and analysis, streamline clinical trial processes, and ensure regulatory compliance.
“Companies are employing AI-driven platforms that generate valuable insights through data analytics to inform decision-making and refine medical affairs strategies,” the report said. Healthcare Asia Magazine